Abstract
We have previously reported a frequent occurrence of paraproteinaemia (monoclonal gammopathy) following allo-SCT. This finding was significantly associated with CMV reactivation in multivariate analysis.1 We did not routinely monitor EBV reactivation in our series, as this was not our practice at that time. The last allo-SCT in that series was performed in 2007, 2 years prior to the publication of the European Conference on Infections in Leukemia guidelines recommending routine EBV viral load monitoring following allo-SCT.2
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
